Aquilon Pharma projects
AEROVID
Aquilon Pharma takes part to and coordinates a technology innovation consortium for the AEROVID project aiming at “Developing cyclodextrin-based inhaled therapies for the management of infection-induced respiratory disorders”.
AERONEXT
Aquilon Pharma takes part to and coordinates a technology innovation consortium for the AERONEXT project aiming at “Developing an improved and innovative inhaled therapies through the combination of an innovative...
Horizon
STOP SPREAD BAD BUGS is a new multi-disciplinary research/training consortium built to combat the alarming problem of global antimicrobial resistance. Multi-drug resistance (MDR) in bacteria is becoming increasingly common thus...
BORA BOREAS
Aquilon Pharmaceuticals has passed an important milestone in the development of its first treatment AQ001S, based on a technological complex combining Budesonide and a Cyclodextrin (HP-Betadex).
Contact us
Do you have a question? Let's get in touch.